FERINJECT

This brand name is authorized in Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, UK.

Active ingredients

The drug FERINJECT contains one active pharmaceutical ingredient (API):

1
UNII 02414N8GQC - DEXTRIFERRON
 
Read more about Iron polymaltose

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 FERINJECT Solution for injection/infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
B03AB05 Ferric oxide polymaltose complexes B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AB Iron trivalent, oral preparations
Discover more medicines within B03AB05
B03AC Iron trivalent, parenteral preparations B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 10104T, 11702X
BR Câmara de Regulação do Mercado de Medicamentos 501113010020402
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 1867-MEE-0316
EE Ravimiamet 1236934, 1236945, 1387795, 1387807, 1548233, 1548244, 1671500, 1862535
ES Centro de información online de medicamentos de la AEMPS 69771
FI Lääkealan turvallisuus- ja kehittämiskeskus 145795, 145817, 400244
FR Base de données publique des médicaments 60960624
GB Medicines & Healthcare Products Regulatory Agency 137526, 137529, 243929
HK Department of Health Drug Office 64137, 64138
HR Agencija za lijekove i medicinske proizvode HR-H-646532651
IL מִשְׂרַד הַבְּרִיאוּת 6674
JP 医薬品医療機器総合機構 3222404A1021
LT Valstybinė vaistų kontrolės tarnyba 1022620, 1022621, 1035297, 1035298, 1062875, 1062876, 1072065
NL Z-Index G-Standaard 15467112
NL Z-Index G-Standaard, PRK 115088, 89230, 89249
NZ Medicines and Medical Devices Safety Authority 15189
PL Rejestru Produktów Leczniczych 100220253
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W59531001, W59531002, W59531003, W59531004, W59531005, W59531006
SG Health Sciences Authority 14035P
TN Direction de la Pharmacie et du Médicament 6653701H
ZA Health Products Regulatory Authority 45/8.3/0948

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.